ANDA 201513, held by Lupin. Sevelamer Carbonate.
As of Nov 16, 2026, ANDA 201513 (Sevelamer Carbonate), held by Lupin, was first approved by FDA on Dec 23, 2021, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 23, 2021 | Original application | Approved | None posted |
| Sevelamer Carbonate800MG/PACKET · for suspension;oral | Sevelamer Carbonate | Discontinued |
| Sevelamer Carbonate2.4GM/PACKET · for suspension;oral | Sevelamer Carbonate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters